Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tumor Microenvironment Alteration During Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer Patients

NCT06533670 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT06533670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06533670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tumor Microenvironment Alteration During Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer Patients
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
July 19, 2024
Completion date
July 19, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, chemotherapy effect, her2-positive breast cancer